BioXcel Therapeutics is a Connecticut-based biopharmaceutical company that develops transformative medicines for the treatment of neurodegenerative disorders and cancer.
Business Model:
Revenue: $137k
Employees: 51-200
Address: 555 Long Wharf Drive
City: New Haven
State: CT
Zip: 06511
Country: US
BioXcel Therapeutics is a Connecticut-based biopharmaceutical company that develops transformative medicines for the treatment of neurodegenerative disorders and cancer.
Contact Phone:
+14752386837
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/16/2018
Ticker Symbol:
BTAI
IPO Price:
$11.374046270849858/share
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2022 | Post-IPO Debt | 2 | $135M |
Oaktree Capital Management Qatar Investment Authority Oaktree Capital Management Qatar Investment Authority |
4/2022 | Post-IPO Equity | 2 | $5M |
Oaktree Capital Management Qatar Investment Authority Oaktree Capital Management Qatar Investment Authority |
4/2022 | Post-IPO Equity | $260M |
Oaktree Capital Management, L.P. Qatar Investment Authority |
6/2021 | Post-IPO Equity | $100M | 9/2019 | Post-IPO Equity | $19M | 7/2020 | Post-IPO Equity | $200M | 2/2020 | Post-IPO Equity | $64M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|